Work

IL-5 Inhibitor Treatment in Drug Reaction With Eosinophilia and Systemic Symptoms

Year: 2025

Type: article

Abstract: This case series evaluates the safety and efficacy of IL-5 inhibition for the treatment of drug reaction with eosinophilia and systemic symptoms.

Source: JAMA Dermatology

DOI: 10.1001/jamadermatol.2025.0441

Authors: Baraa Hijaz, Vinod E. Nambudiri, Sotonye Imadojemu

Institutions: Brigham and Women's Hospital, Harvard University

Language: English

Topic: Eosinophilic Disorders and Syndromes

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4409485487

FWCI: 1.879

Cites: 6

Cited by: 3

Related to: 10